1. Angiotensin-neprilysin inhibition versus enalapril in heart failure;McMurray;N. Engl. J. Med.,2014
2. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
3. Ejection fraction improvement and reverse remodeling achieved with Sacubitril/Valsartan in heart failure with reduced ejection fraction patients;Almufleh;Am. J. Cardiovasc. Dis.,2017
4. Impact of sacubitril/valsartan on echo parameters in heart failure patients with reduced ejection fraction a prospective evaluation;Bayard;Int. J. Cardiol. Heart Vasc.,2019
5. Effect of sacubitril-valsartan vs enalapril on aortic stiffness in patients with heart failure and reduced ejection fraction: a randomized clinical trial;Desai;JAMA,2019